Grey water treatment and circular economy
- PMID: 40517706
- DOI: 10.1016/j.chemosphere.2025.144433
Grey water treatment and circular economy
Abstract
Owing to the continuous decline in freshwater availability in many parts of the world, emphasis has been placed on sustainable utilization of available water. The reuse of treated wastewater generated from household activities, especially greywater, for non-potable purposes, could be a solution to the current situation. Several technologies have been developed for greywater treatment. The quality of greywater varies depending on the products being used for household activities; therefore, no single process can treat greywater up to the required quality standard for a long duration. Various combinations of treatment processes have been tested worldwide. The residue produced during the treatment process was promoted for use as a resource. This review focuses on the reported greywater characteristics, treatment technologies available for greywater, and technologies reported for the reuse of residues produced after greywater treatment.
Keywords: Greywater; Greywater characteristics; Greywater residue; Resource recovery; Treatment technologies.
Copyright © 2025 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Cost-effectiveness of regenerated green materials for removal of pharmaceuticals from wastewater.Waste Manag. 2025 Aug 1;204:114952. doi: 10.1016/j.wasman.2025.114952. Epub 2025 Jun 17. Waste Manag. 2025. PMID: 40532387 Review.
-
Use of recovered coagulant from water treatment sludge for greywater treatment.Environ Sci Pollut Res Int. 2025 Jun;32(30):18209-18225. doi: 10.1007/s11356-025-36713-9. Epub 2025 Jul 14. Environ Sci Pollut Res Int. 2025. PMID: 40659996
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Assessing the comparative effects of interventions in COPD: a tutorial on network meta-analysis for clinicians.Respir Res. 2024 Dec 21;25(1):438. doi: 10.1186/s12931-024-03056-x. Respir Res. 2024. PMID: 39709425 Free PMC article. Review.
-
Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.Health Technol Assess. 2006 Sep;10(34):iii-iv, ix-xi, 1-204. doi: 10.3310/hta10340. Health Technol Assess. 2006. PMID: 16959170
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources